2.370USD-1.66%Mkt Cap: 35.50M USDP/E: —Last update: 2026-05-22
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap35.50M USD
Enterprise Value19.20M USD
Revenue (TTM)1.16M USD
Gross Profit734.39K USD
Net Income (TTM)-13.40M USD
Revenue/Share0.0920 USD
Last Price2.370 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.73
PEG—
EV/EBITDA-1.93
EV/Revenue16.59
P/S31.20
P/B48.20
EPS (TTM)-0.91
EPS (Forward)-0.51
52W Range
1.27014% of range9.190
52W High9.190 USD
52W Low1.270 USD
Profitability
Gross Margin71.29%
Oper. Margin-1967.07%
EBITDA Margin0.00%
Profit Margin-1300.66%
ROE-471.37%
ROA-41.26%
Growth
Revenue Growth499.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.89M USD
CapEx (TTM)385.28K USD
FCF Margin-414.07%
FCF Yield-13.50%
Net Debt-16.91M USD
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.93
Current Ratio1.03
Quick Ratio0.91
Book Value/Sh0.0500 USD
Cash/Share1.236 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 20, 2017
Splits
Last Split1:12
Split DateJul 1, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)9.667 USD
Target Range8.000 USD – 12.00 USD
# Analysts3
Ownership
Shares Out.14.98M
Float13.70M
Insiders8.08%
Institutions8.39%
Short Interest
Short Ratio0.4d
Short % Float2.48%
Short % Out.2.46%
Shares Short358.08K
Short (prev mo.)211.49K
Technical
SMA 502.094 (+13.2%)
SMA 2001.986 (+19.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)1.13M
Avg Vol (10d)669.87K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—